First Time Loading...

Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.42 AUD -6.67% Market Closed
Updated: Apr 27, 2024

Intrinsic Value

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. [ Read More ]

The intrinsic value of one IMM stock under the Base Case scenario is 2.26 AUD. Compared to the current market price of 0.42 AUD, Immutep Ltd is Undervalued by 81%.

Key Points:
IMM Intrinsic Value
Base Case
2.26 AUD
Undervaluation 81%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Immutep Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IMM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Immutep Ltd

Provide an overview of the primary business activities
of Immutep Ltd.

What unique competitive advantages
does Immutep Ltd hold over its rivals?

What risks and challenges
does Immutep Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Immutep Ltd.

Provide P/S
for Immutep Ltd.

Provide P/E
for Immutep Ltd.

Provide P/OCF
for Immutep Ltd.

Provide P/FCFE
for Immutep Ltd.

Provide P/B
for Immutep Ltd.

Provide EV/S
for Immutep Ltd.

Provide EV/GP
for Immutep Ltd.

Provide EV/EBITDA
for Immutep Ltd.

Provide EV/EBIT
for Immutep Ltd.

Provide EV/OCF
for Immutep Ltd.

Provide EV/FCFF
for Immutep Ltd.

Provide EV/IC
for Immutep Ltd.

Show me price targets
for Immutep Ltd made by professional analysts.

What are the Revenue projections
for Immutep Ltd?

How accurate were the past Revenue estimates
for Immutep Ltd?

What are the Net Income projections
for Immutep Ltd?

How accurate were the past Net Income estimates
for Immutep Ltd?

What are the EPS projections
for Immutep Ltd?

How accurate were the past EPS estimates
for Immutep Ltd?

What are the EBIT projections
for Immutep Ltd?

How accurate were the past EBIT estimates
for Immutep Ltd?

Compare the revenue forecasts
for Immutep Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Immutep Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Immutep Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Immutep Ltd compared to its peers.

Compare the P/E ratios
of Immutep Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Immutep Ltd with its peers.

Analyze the financial leverage
of Immutep Ltd compared to its main competitors.

Show all profitability ratios
for Immutep Ltd.

Provide ROE
for Immutep Ltd.

Provide ROA
for Immutep Ltd.

Provide ROIC
for Immutep Ltd.

Provide ROCE
for Immutep Ltd.

Provide Gross Margin
for Immutep Ltd.

Provide Operating Margin
for Immutep Ltd.

Provide Net Margin
for Immutep Ltd.

Provide FCF Margin
for Immutep Ltd.

Show all solvency ratios
for Immutep Ltd.

Provide D/E Ratio
for Immutep Ltd.

Provide D/A Ratio
for Immutep Ltd.

Provide Interest Coverage Ratio
for Immutep Ltd.

Provide Altman Z-Score Ratio
for Immutep Ltd.

Provide Quick Ratio
for Immutep Ltd.

Provide Current Ratio
for Immutep Ltd.

Provide Cash Ratio
for Immutep Ltd.

What is the historical Revenue growth
over the last 5 years for Immutep Ltd?

What is the historical Net Income growth
over the last 5 years for Immutep Ltd?

What is the current Free Cash Flow
of Immutep Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Immutep Ltd.

Financials

Balance Sheet Decomposition
Immutep Ltd

Current Assets 113m
Cash & Short-Term Investments 103.7m
Receivables 6.1m
Other Current Assets 3.2m
Non-Current Assets 10.8m
PP&E 795.5k
Intangibles 8.7m
Other Non-Current Assets 1.2m
Current Liabilities 6.6m
Accounts Payable 3m
Accrued Liabilities 472.8k
Other Current Liabilities 3.1m
Non-Current Liabilities 1.6m
Long-Term Debt 1.4m
Other Non-Current Liabilities 184.5k
Efficiency

Earnings Waterfall
Immutep Ltd

Revenue
256.6k AUD
Operating Expenses
-47.2m AUD
Operating Income
-46.9m AUD
Other Expenses
6.4m AUD
Net Income
-40.5m AUD

Free Cash Flow Analysis
Immutep Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

IMM Profitability Score
Profitability Due Diligence

Immutep Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROE is Increasing
Negative 1-Year Revenue Growth
Declining ROIC
18/100
Profitability
Score

Immutep Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

IMM Solvency Score
Solvency Due Diligence

Immutep Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Immutep Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IMM Price Targets Summary
Immutep Ltd

Wall Street analysts forecast IMM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMM is 1.28 AUD with a low forecast of 0.66 AUD and a high forecast of 2.84 AUD.

Lowest
Price Target
0.66 AUD
56% Upside
Average
Price Target
1.28 AUD
205% Upside
Highest
Price Target
2.84 AUD
575% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

IMM Price
Immutep Ltd

1M 1M
+14%
6M 6M
+33%
1Y 1Y
+62%
3Y 3Y
-2%
5Y 5Y
-85%
10Y 10Y
-89%
Annual Price Range
0.42
52w Low
0.225
52w High
0.45
Price Metrics
Average Annual Return -13.72%
Standard Deviation of Annual Returns 67.24%
Max Drawdown -99%
Shares Statistics
Market Capitalization 499.3m AUD
Shares Outstanding 1 188 829 952
Percentage of Shares Shorted
N/A

IMM Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Immutep Ltd Logo
Immutep Ltd

Country

Australia

Industry

Biotechnology

Market Cap

499.3m AUD

Dividend Yield

0%

Description

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. The company is headquartered in Sydney, New South Wales. The firm is engaged in the development of LAG-3 immunotherapeutic products for cancer and autoimmune disease. The firm has four product candidates based on the LAG-3 immune control mechanism. Its lead product candidate, eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein, which is in later-stage clinical development for the treatment of cancer. Its second product candidate (IMP761) is in pre-clinical development for the treatment of autoimmune disease. The Company’s two licensed product candidates include Antagonist AB (LAG525) and Depleting AB (GSK‘781). The Company’s operates through its subsidiaries, which includes Immutep USA Inc, PRR Middle East FZ LLC, Immutep GmbH, Immutep Australia Pty Ltd, Immutep IP Pty Ltd and Immutep S.A.S.

Contact

NEW SOUTH WALES
Sydney
Plaza Building, L 12 95 Pitt St
+61292761224.0
http://www.immutep.com/

IPO

1988-06-23

Employees

-

Officers

CEO, MD, CFO, Chief Business Officer & Executive Director
Mr. Marc Voigt
COO, General Counsel & Joint Company Secretary
Ms. Deanne Miller LLB
Chief Scientific Officer & Executive Director
Dr. Frederic Triebel M.D., Ph.D.
Senior Vice President of Regulatory & Strategy
Mr. Christian Mueller BBA, MSc.
Chief Medical Officer
Mr. Florian D. Vogl M.D., M.Sc., Ph.D.
Joint Company Secretary
Ms. Indira Naidu

See Also

Discover More
What is the Intrinsic Value of one IMM stock?

The intrinsic value of one IMM stock under the Base Case scenario is 2.26 AUD.

Is IMM stock undervalued or overvalued?

Compared to the current market price of 0.42 AUD, Immutep Ltd is Undervalued by 81%.